RecruitingPhase not listedNCT07875192
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
Sponsor: Central Ohio Urology Group
Columbus, OH
Prostate Cancer clinical trials in Columbus, OH
12 recruiting prostate cancer studies with a site in Columbus, OH.
RecruitingPhase 2NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Sponsor: National Cancer Institute (NCI)
Columbus, OH · +12 more sites
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Cincinnati, OH · Columbus, OH · +16 more sites
RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Cincinnati, OH · Columbus, OH · Dayton, OH · +42 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
Columbus, OH · +23 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Cincinnati, OH · +338 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Akron, OH · Avon, OH · Beachwood, OH · +371 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Columbus, OH · +23 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Columbus, OH · +13 more sites
RecruitingPhase 2NCT06330805
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Sponsor: Ohio State University Comprehensive Cancer Center
Columbus, OH
RecruitingPhase 1 / Phase 2NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Sponsor: Tanabe Pharma America, Inc.
Columbus, OH · +3 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Columbus, OH · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.